SARS-CoV-2 Nucleocapsid and Membrane proteins (N and M proteins)

The SARS-CoV-2 Nucleocapsid (N) and Membrane (M) proteins are essential structural components of the virus responsible for COVID-19. The N protein is a multifunctional phosphoprotein that binds to the viral RNA genome, forming the ribonucleoprotein (RNP) complex and facilitating genome packaging, replication, and transcription (1, 22). The M protein is the most abundant structural protein, serving as the central organizer of viral assembly by interacting with the N, Spike (S), and Envelope (E) proteins to drive the formation of the viral envelope (3, 10). Together, these proteins play critical roles in viral morphogenesis, budding, and the modulation of host immune responses, such as the inhibition of interferon production (11, 21). While most current vaccines target the Spike protein, the N and M proteins are highly conserved across variants, making them attractive targets for broad-spectrum antiviral drugs and T-cell-inducing vaccines (12, 13). Experimental small molecules like JNJ-9676 and CIM-834 aim to disrupt viral assembly by targeting the M protein, while compounds like K31 target the N protein to inhibit RNA binding (11, 12). Because this target entry combines two distinct proteins with different primary functions, it is technically classified as containing multiple targets, though they are functionally linked during the viral life cycle (14, 23).

Other names

SARS-CoV-2 N proteinSARS-CoV-2 M proteinNucleoproteinPhosphoprotein NMembrane glycoproteinMatrix proteinSARS-CoV-2 structural proteins

Inhibition of viral assembly and morphogenesis by disrupting M-protein dimerization or M-N protein interactions; blockade of viral RNA binding and encapsidation by targeting the N-protein RNA-binding domain; and inhibition of N-protein phosphorylation via host kinase interference to impair viral replication.